- Report
- January 2025
- 250 Pages
Global
From €4478EUR$4,999USD£3,817GBP
- Report
- June 2025
Global
From €4389EUR$4,900USD£3,741GBP
- Report
- March 2025
- 200 Pages
Global
From €2230EUR$2,490USD£1,901GBP
- Report
- May 2025
- 199 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 191 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- February 2025
- 146 Pages
Global
From €2686EUR$2,999USD£2,290GBP
- Report
- January 2025
- 126 Pages
Global
From €2686EUR$2,999USD£2,290GBP
- Report
- August 2024
- 135 Pages
Global
From €2686EUR$2,999USD£2,290GBP
- Report
- August 2024
- 149 Pages
Global
From €2686EUR$2,999USD£2,290GBP
- Report
- August 2024
- 100 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- February 2025
- 70 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- March 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- March 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- March 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- January 2025
- 200 Pages
Global
From €2230EUR$2,490USD£1,901GBP
- Report
- August 2024
- 177 Pages
Global
From €2239EUR$2,500USD£1,909GBP
- Report
- June 2025
- 73 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 250 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- April 2025
- 175 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- April 2025
- 175 Pages
Global
From €4022EUR$4,490USD£3,428GBP

Pneumonia is an infectious disease caused by bacteria, viruses, or fungi that affects the lungs. It is one of the most common infectious diseases and is a leading cause of death worldwide. Infectious disease testing is used to diagnose and monitor the progression of pneumonia. Tests used to diagnose pneumonia include chest X-rays, sputum cultures, and blood tests. Treatment for pneumonia typically involves antibiotics, antivirals, and other medications.
The pneumonia market within the context of infectious disease testing is a rapidly growing market. It is driven by the increasing prevalence of pneumonia, the development of new diagnostic technologies, and the increasing demand for rapid and accurate diagnosis. The market is expected to grow due to the increasing prevalence of pneumonia, the development of new diagnostic technologies, and the increasing demand for rapid and accurate diagnosis.
Some companies in the pneumonia market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more